{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T19:40:47Z","timestamp":1782762047560,"version":"3.54.5"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Importance<\/jats:title><jats:p>The direct antiglobulin test (DAT) is commonly used as a screening test for predicting significant neonatal hyperbilirubinemia requiring intervention. However, evidence for this approach is limited.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>The aim of this study was to evaluate the diagnostic utility of DAT in predicting the need for phototherapy and double volume exchange transfusion (DVET) in neonates with ABO and Rhesus (Rh) incompatibility conditions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>MEDLINE, Embase, CENTRAL, CINAHL, and Web of Science were searched from inception until 1 February 2024. Randomized controlled trials (RCTs) and non-RCTs were eligible for inclusion. Two reviewers screened the titles and abstracts blinded to each other. A Bayesian bivariate random-effects model was employed for the diagnostic test accuracy meta-analyses. Risk of bias was assessed using Quality Assessment for Studies of Diagnostic Accuracy 2 and certainty of evidence (CoE) was adjudged according to the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) guidelines.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 53 studies were included in the systematic review and 28 were synthesized in the meta-analysis. For the need for phototherapy outcome, the pooled sensitivity [95% credible interval (CrI)] and specificity (95% CrI) of DAT in ABO incompatibility (18 studies, <jats:italic>n<\/jats:italic>\u2009=\u200910,110) were 56.1% (44.5%\u201367.8%) and 83.6% (71.6%\u201390.8%). For Rh incompatibility (three studies, <jats:italic>n<\/jats:italic>\u2009=\u2009491), the sensitivity and specificity were 40.4% (12.2%\u201381.7%) and 89.9% (72.7%\u201394.6%). The CoE was predominantly low. For the need for DVET outcome, the pooled sensitivity and specificity of DAT in ABO incompatibility (three studies, <jats:italic>n<\/jats:italic>\u2009=\u20092,652) were 83.6% (35.8%\u201399.6%) and 74.5% (40.3%\u201392.7%). For Rh incompatibility (two studies, <jats:italic>n<\/jats:italic>\u2009=\u2009240), the sensitivity and specificity were 80.3% (34.2%\u201397.3%) and 68.0% (25.3%\u201392.1%). The CoE was predominantly very low.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In ABO and Rh incompatibility, DAT probably has moderate specificity and low sensitivity for predicting the need for phototherapy. For DVET, though DAT is possibly a better predictor due to its acceptable sensitivity, the predictive interval was wide. Thus, we do not suggest the routine use of DAT screening to predict the need for phototherapy and DVET. However, it may be used as a second-tier investigation for risk stratification of high-risk neonates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic Review Registration<\/jats:title><jats:p><jats:uri>https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42022297785<\/jats:uri>, PROSPERO (CRD42022297785).<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2024.1475623","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T06:44:32Z","timestamp":1738046672000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Direct antiglobulin test for the prediction of neonatal hyperbilirubinemia needing an intervention: a systematic review and diagnostic test accuracy meta-analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Vijay","family":"Kumar Krishnegowda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viraraghavan Vadakkencherry","family":"Ramaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thangaraj","family":"Abiramalatha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapas","family":"Bandyopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Kareem Pullattayil","family":"S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Kannan Loganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e2022058859","DOI":"10.1542\/peds.2022-058859","article-title":"Clinical practice guideline revision: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation","volume":"150","author":"Kemper","year":"2022","journal-title":"Pediatrics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1542\/peds.114.1.297","article-title":"Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation","volume":"114","year":"2004","journal-title":"Pediatrics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e2023062335","DOI":"10.1542\/peds.2023-062335","article-title":"Transcutaneous bilirubin accuracy before, during, and after phototherapy: a meta-analysis","volume":"152","author":"Ten Kate","year":"2023","journal-title":"Pediatrics"},{"key":"B4","article-title":"Jaundice in newborn babies under 28 days","year":"2010"},{"key":"B5","article-title":"2023 exceptional surveillance of jaundice in newborns under 28 days (NICE guideline CG98). National Institute for Health and Care Excellelnce","year":"2023"},{"key":"B6","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1136\/archdischild-2013-305553","article-title":"How to use: the direct antiglobulin test in newborns","volume":"100","author":"Keir","year":"2015","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"B7","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/jp.2012.26","article-title":"Outcome and cost analysis of implementing selective Coombs testing in the newborn nursery","volume":"32","author":"Shahid","year":"2012","journal-title":"J Perinatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e1340","DOI":"10.1542\/peds.2014-1290","article-title":"Direct antiglobulin titer strength and hyperbilirubinemia","volume":"134","author":"Kaplan","year":"2014","journal-title":"Pediatrics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3109\/14767058.2013.819335","article-title":"Is the strength of direct antiglobulin test important for the duration of phototherapy?","volume":"27","author":"Oztekin","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2147\/JBM.S291606","article-title":"Value of the direct antiglobulin test in predicting the need for phototherapy in newborns","volume":"12","author":"AlKhater","year":"2021","journal-title":"J Blood Med"},{"key":"B11","article-title":"PROSPERO home page","year":""},{"key":"B12","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br Med J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"B15","article-title":"Cochrane handbook for systematic reviews of diagnostic test accuracy","author":"Macaskill","year":""},{"key":"B16","volume-title":"R: A Language and Environment for Statistical Computing","year":"2023"},{"key":"B17","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v083.i01","article-title":"meta4diag: Bayesian Bivariate Meta-Analysis of Diagnostic Test Studies for Routine Practice","author":"Guo","year":""},{"key":"B18","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jclinepi.2021.04.001","article-title":"GRADE Guidance: 31. Assessing the certainty across a body of evidence for comparative test accuracy","volume":"136","author":"Yang","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s12288-021-01513-x","article-title":"Predicting significant hyperbilirubinemia in ABO incompatibility: is cord direct antiglobulin test useful?","volume":"38","author":"Chowdhary","year":"2022","journal-title":"Indian J Hematol Blood Transfus"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/s41372-023-01650-3","article-title":"Rates of phototherapy among ABO-incompatible newborns with a negative direct antiglobulin test","volume":"43","author":"Gabbay","year":"2023","journal-title":"J Perinatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.21307\/immunohematology-2023-009","article-title":"Significance of immunohematologic testing in mother and newborn ABO incompatibility","volume":"39","author":"Novoselac","year":"2023","journal-title":"Immunohematology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1590\/1806-9282.20220047","article-title":"Maternal-fetal alloimmunization: perinatal outcomes in a reference hospital in Northeastern Brazil","volume":"68","author":"Duete","year":"2022","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.pedneo.2021.04.002","article-title":"Direct antiglobulin test in the prediction of hyperbilirubinemia and predischarge bilirubin levels in infants with mother-infant blood type incompatibility","volume":"62","author":"Mehta","year":"2021","journal-title":"Pediatr Neonatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jped.2020.08.009","article-title":"Cord blood bilirubin and prediction of neonatal hyperbilirubinemia and perinatal infection in newborns at risk of hemolysis","volume":"97","author":"Kardum","year":"2021","journal-title":"J Pediatr (Rio J)"},{"key":"B25","first-page":"A117","article-title":"Neonatal hemolysis risk assessment in the era of universal bilirubin screening","volume":"68","author":"Ligsay","year":"2020","journal-title":"J Invest Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/labmed\/lmz029","article-title":"An automated method for direct antiglobulin testing and the resulting amount of phototherapy used at a large academic medical center","volume":"51","author":"Fei","year":"2020","journal-title":"Lab Medicine"},{"key":"B27","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/labmed\/lmy050","article-title":"Characteristics of bilirubin according to the results of the direct antiglobulin test and its impact in hemolytic disease of the newborn","volume":"50","author":"Shin","year":"2019","journal-title":"Lab Med"},{"key":"B28","first-page":"330","article-title":"Is the phototherapy requirement in neonatal hyperbilirubinemia due to AB0 incompatibility predictable?","volume":"13","author":"Altuntas","year":"2019","journal-title":"Turk J Pediatr Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1111\/trf.14229","article-title":"Prevalence of positive direct antiglobulin test and clinical outcomes in Surinamese newborns from D-negative women","volume":"57","author":"Zonneveld","year":"2017","journal-title":"Transfusion"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1001\/archpediatrics.2010.242","article-title":"Hour-specific bilirubin nomogram in infants with ABO incompatibility and direct Coombs-positive results","volume":"164","author":"Schutzman","year":"2010","journal-title":"Arch Pediatr Adolesc Med"},{"key":"B31","first-page":"324","article-title":"Predictive value of the direct antiglobulin test in cordblood","volume":"24","author":"Van Geelkerken","year":"1999","journal-title":"Nederlands Tijdschrift Voor de Klinische Chemie"},{"key":"B32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/02724936.1993.11747654","article-title":"ABO and Rh(D) blood group distribution and their implication for feto-maternal incompatibility among the Palestinian population","volume":"13","author":"Dudin","year":"1993","journal-title":"Ann Trop Paediatr"},{"key":"B33","first-page":"248","article-title":"[Value of the Coombs test in ABO incompatibility]","volume":"35","author":"Bel Comos","year":"1991","journal-title":"Valor del test de Coombs en la incompatibilidad ABO"},{"key":"B34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1440-1754.1988.tb01329.x","article-title":"Haematolytic disease due to ABO incompatibility: incidence and value of screening in an Asian population","volume":"24","author":"Han","year":"1988","journal-title":"Aust Paediatr J"},{"key":"B35","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1055\/a-1709-5036","article-title":"Positive direct antiglobulin test: is it a risk factor for significant hyperbilirubinemia in neonates with ABO incompatibility?","volume":"41","author":"Ercin","year":"2024","journal-title":"Am J Perinatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3233\/NPM-221136","article-title":"A retrospective comparison of phototherapy need in O-B versus O-A incompatibility in a single Saudi institution","volume":"16","author":"Al-Omran","year":"2023","journal-title":"J Neonatal Perinatal Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1111\/j.1651-2227.2009.01478.x","article-title":"Maternal IgG anti-A and anti-B titres predict outcome in ABO-incompatibility in the neonate","volume":"98","author":"Bakkeheim","year":"2009","journal-title":"Acta Paediatr"},{"key":"B38","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jgyn.2010.02.006","article-title":"[What blood tests to predict severe hyperbilirubinemia in early maternity discharge?]","volume":"39","author":"Tatopoulos","year":"2010","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1542\/peds.109.4.e53","article-title":"An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility","volume":"109","author":"Sarici","year":"2002","journal-title":"Pediatrics"},{"key":"B40","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1001\/archfami.2.3.285","article-title":"The clinical significance of ABO blood group incompatibility","volume":"2","author":"Madlon-Kay","year":"1993","journal-title":"Arch Fam Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0140-6736(88)90466-7","article-title":"What is the best predictor of the severity of ABO-haemolytic disease of the newborn?","volume":"2","author":"Brouwers","year":"1988","journal-title":"Lancet"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1111\/j.1651-2227.1998.tb00950.x","article-title":"Screening for neonatal hyperbilirubinaemia and ABO alloimmunization at the time of testing for phenylketonuria and congenital hypothyreosis","volume":"87","author":"Meberg","year":"1998","journal-title":"Acta Paediatr"},{"key":"B43","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1651-2227.1981.tb05545.x","article-title":"Prediction of the severity of ABO haemolytic disease of the newborn by cord blood tests","volume":"70","author":"Whyte","year":"1981","journal-title":"Acta Paediatr Scand"},{"key":"B44","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1542\/peds.61.3.475","article-title":"ABO Hemolytic disease of the newborn: evaluation of management and identification of racial and antigenic factors","volume":"61","author":"Peevy","year":"1978","journal-title":"Pediatrics"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1055\/a-2255-8772","article-title":"A description of IVIG use in term neonates with ABO incompatibility","volume":"41","author":"Daunov","year":"2024","journal-title":"Am J Perinatol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"F83","DOI":"10.1136\/adc.2005.076794","article-title":"Haemolytic disease of the newborn","volume":"92","author":"Murray","year":"2007","journal-title":"Arch Dis Child Fetal Neonatal Ed"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1475623\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T06:44:36Z","timestamp":1738046676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1475623\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":46,"alternative-id":["10.3389\/fped.2024.1475623"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1475623","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"article-number":"1475623"}}